No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Neoadjuvant atezolizumab is not effective for node-positive HER2⁺ breast cancer

byTeddy Guo

October 11, 2022

in StudyGraphics

Reading Time: 1 min read

Vitamin D3 and omega-3 fatty acid supplementation does not protect against frailty

RelatedReports

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Statin use after but not before breast cancer diagnosis is associated with improved mortality in hormone receptor-positive early breast cancer

June 8, 2026

Weekly Rewinds

2 Minute Medicine Rewind June 8, 2026

June 8, 2026

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Oncology

Why Pfizer Is Looking East for Its Next Generation of Cancer Drugs

June 4, 2026

Pharma

2MM: Pharma Roundup – Pfizer’s $10.5B Innovent oncology partnership, Guselkumab (Tremfya) gains a broader psoriatic arthritis label, Venetoclax (Venclyxto) expands first-line CLL options, and Seladelpar (Livdelzi) advances in primary biliary cholangitis

June 3, 2026

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Dapagliflozin associated with reduction in cardiovascular mortality due to lower rates of death from heart failure and sudden death – Pooled analysis of DAPA-HF and DELIVER

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact

Atezolizumab does not reduce post-resection recurrence in patients with renal cell carcinoma

Collaborative home-based palliative care approach effective for heart failure patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports